A rare case of paraneoplastic cerebellar degeneration (with detectable antineuronal antibody anti-Yo) is described, where 18F-FDG-PET/CT aided in detection of two synchronous malignancies (one thyroid cancer and the other breast cancer); interestingly, the primary breast malignancy was non-FDG avid and was detected through the presence of a metastatic FDG-avid axillary lymph node. Surgery for both was undertaken in the same sitting and there was improvement of the neurological features soon after the surgical removal of the malignancies.
Introduction
18F-FDG-PET/PET-CT based molecular imaging has been proposed to be useful in paraneoplastic neurological syndrome (PNS) from the two aspects: (1) aiding in detecting the occult tumor and (2) assessing the functional abnormality in the brain related to the neurological features and disease activity and monitoring them along with brain MRI following therapeutic intervention (1, 2). We herein describe a unique finding in the setting of paraneoplastic cerebellar degeneration (PCD), an entity encompassed under the broad term of paraneoplastic neurological syndrome (PNS), where 18F-FDG-PET/CT helped diagnosing two synchronous malignancies, of which one was metastatic lesion, the primary being non 18F-FDG avid (3).
Case Presentation
A 53-year-old female with history of progressive vertigo and dizziness, gait disturbance, slurring of speech, lateralized gaze and occasional episode of syncope since last 4 months and with suspected diagnosis of paraneoplastic cerebellar degeneration was referred for 18F-FDG-PET/CT for whole body survey to rule out malignancy. There was no history of fever or any infection prior to the onset of symptoms. Clinical examination was positive for cerebellar signs. To rule out the vascular etiology, contrast enhanced CT of brain was performed previously, which was normal. Routine blood examinations were normal. Contrast enhanced MRI of the brain was also performed and was normal except for tiny ischemic foci in bilateral frontal lobe. Suspecting paraneoplastic cerebellar syndrome as an etiology, onconeural antibodies (anti-Hu, anti-Yo, etc) were considered and only anti-neuronal antibody antiYo was positive. The whole body 18F-FDG-PET/CT (Fig 1a, 1b, 1c 
